Identity
- Security key
- 18074
- Ticker
- LITS
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2003-12-18
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- LITS
Detail
Enriched 2026-08-14 20:47
- Market cap
- $31,354,221.8
- Shares outstanding (class)
- 34,025,200
- Shares outstanding (weighted)
- 34,025,200
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 4
- Location
- SAN DIEGO, CA
- Homepage
- https://www.litestrategy.com
- Description
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.